France Physiotherapy Equipment Market Analysis

France Physiotherapy Equipment Market Executive Summary

The France Physiotherapy Equipment Market is at around $574.75 Mn in 2023 and is projected to reach $875.69 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period.

Physiotherapy equipment refers to the instruments that physiotherapists use to help cases recover from accidents, operations, or habitual conditions. These include exercise cycles, ultrasound machines, and resistance bands. The utilization of physiotherapy equipment can help reduce the level of care required for these patients.

Musculoskeletal conditions encompass a wide range of conditions and conditions affecting the muscles, bones, joints, and connective tissues, leading to pain, mobility limitations, and reduced functioning. These conditions include low reverse pain, neck pain, fractures, osteoarthritis, amputations, rheumatoid arthritis, and other musculoskeletal issues. Musculoskeletal diseases affect limited mobility and are a significant cause of disability. The French Musculoskeletal Disorders Surveillance Program found high prevalence rates of Musculoskeletal disorders (MSDs), with 11% of men and 15% of women having at least one of the six main upper limb clinically diagnosed MSDs.

The market therefore is driven by significant factors like the aging population and the rising prevalence of cardiovascular, neurological, and musculoskeletal diseases. Advancements in technology, favorable reimbursement scenario, rising healthcare expenditures also play a key role in market growth.  However, limited accessibility to specialized physiotherapists, high cost of physiotherapy equipment and strict regulatory approval restrict the growth of the market

The leading pharmaceutical companies include Kinvent Biomécanique SAS and Albatros France for physiotherapy equipment. Gymna France and Winback Medical are also significant contributors to the physiotherapy equipment landscape, with continuous research and development activities.

Market Dynamics

Market Growth Drivers

Rise in Geriatric Population: The need for geriatric physiotherapy has grown as a result of the 0.47% increase in the prevalence of arthritis overall, which leaves older adults more susceptible to co-morbid conditions like diabetes, visual impairment, hearing loss, and cardiovascular degeneration. Additionally, producers are heavily investing in creating cutting-edge physiotherapy equipment for the elderly to lessen the severity of their suffering. In the upcoming years, there will be a rise in the prevalence of age-related physical and psychological conditions.

Increasing Technical Progress: Companies are progressively focused on technological advancements and developing new equipment’s to provide superior and user-friendly devices. The development of advanced physiotherapy equipment with enhanced capabilities, such as electrotherapy and cryotherapy devices, drives market growth by providing more effective treatment options.

Favorable Reimbursement Scenario: Physiotherapy services are reimbursed by the national health insurance system, known as the "Sécurité sociale", at a rate of around 70-80% of the cost for most patients. This favorable reimbursement scenario encourages the adoption of physiotherapy equipment.

Rising Healthcare Expenditure: France has a high level of healthcare expenditure, which is primarily financed by the government through taxes and social security contributions. This high expenditure supports the growth of the physiotherapy equipment market.

Market Restraints

Lack of Skilled Physiotherapists: Lack of adequately trained physiotherapists and healthcare providers may hinder the implementation of physiotherapy tools due to patients' inability to receive care from proficient individuals. It also limits the adoption of new technologies, especially in remote areas.

High Cost of Physiotherapy Equipment: High-priced physiotherapy equipment can be a barrier, especially in regions with weak healthcare infrastructure. Patients in these areas often have limited resources, making it difficult to afford or access the equipment needed for proper physiotherapy treatment. This can widen the gap in physiotherapy services between well-funded and under-resourced areas.

Regulatory Obstacles: France's regulatory agency, ANSM (Agence nationale de sécurité du médicament et des produits de santé), has a lengthy and demanding approval process for physiotherapy equipment. This significantly delays new equipment from reaching the market.  Companies hoping to enter the French physiotherapy market face substantial hurdles, potentially hindering the overall growth and innovation in this sector.

Regulatory Landscape and Reimbursement Scenario

The Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM) is the primary regulatory body. It is responsible for responsible for overseeing the implementation of the Medical Devices Regulation (MDR) in France.Devices are classified into four classes (I to IV) based on their level of risk. Class I devices pose the lowest risk (e.g., tongue depressors), while Class IV devices pose the highest risk (e.g., pacemakers). The classification determines the level of regulatory scrutiny required for pre-market approval.

The national healthcare system, Sécurité sociale, covers a portion (usually around 70-80%) of physiotherapy treatment costs provided certain conditions are met. For patients with long-term medical conditions like cancer or diabetes, Sécurité sociale may offer increased coverage for certain medical devices used at home.

Competitive Landscape

Key Players

Here are some of the major key players in the France Physiotherapy Equipment Market:

• Kinvent Biomécanique SAS
• Winback Medical
• Millet Innovation
• SAS Physio Med
• Enraf-Nonius B.V.
• Gymna France
• Physio Supplies France
• Albatros France
• Concept Sante
• Zynex Medical Inc.